Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer
Clinical trial NCT06802757 · RECRUITING
Trial details
- NCT number
- NCT06802757
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2026-06-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.